NanoBio Corporation
Novel Intranasal Nanoemulsion Vaccine Adjuvant Also Effective by Subcutaneous and Intramuscular Injection
Published in Vaccine Weekly, December 16th, 2009
NanoBio Corporation announced positive results from studies in mice in which immune responses were evaluated following administration of 5g doses of recombinant H5N1 pandemic flu antigen combined with the company's novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections. The mice that received either SC or IM H5 antigen combined with nanoemulsion had maximal immune responses at least a 1000 fold higher than control animals that received the same antigen IM without the nanoemulsion adjuvant. SC and IM administered NanoBio adjuvanted vaccines should share many of the advantages,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-12-16)
More Articles from Vaccine Weekly
- Canadian Medical Association Journal
Vaccination, antivirals and social distancing may blunt impact of H1N1 influenza - University of Toronto
Availability of vaccine no guarantee public will want it - Alzheimer Disease
Data from University of California advance knowledge in Alzheimer disease - Bacillus Subtilis
New Bacillus subtilis study findings recently were reported by L. Li and co-researchers - HIV/AIDS Vaccine
New HIV/AIDS vaccine data have been reported by Y. Nishiyama and co-authors - HIV/AIDS Vaccine
Reports from University of Amsterdam add new data to research in HIV/AIDS vaccine - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
